• Home
  • Product Portfolio
    • Pre-Natal
    • NAFLD
    • Male Infertility
    • Muscle Wasting
  • Investment
  • Leadership Team
  • More
    • Home
    • Product Portfolio
      • Pre-Natal
      • NAFLD
      • Male Infertility
      • Muscle Wasting
    • Investment
    • Leadership Team
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Product Portfolio
  • Investment
  • Leadership Team

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Muscle Wasting -SARCOPENIA

SNP Therapeutics has developed an algorithm that can identify individuals who have difficulty converting protein into muscle mass. Up to 10% of the population has difficulty creating muscle mass due to (variant genes) or SNPs preventing the proper metabolism of one carbon nutrients.  Thirty Two Million Americans suffer with Muscle wasting. The market is forecast to grow to nearly $4Bn by 2024. 


SNP Therapeutics is well positioned to participate in this growing market with potential products focusing in the Sports Nutrition and Aging Consumer Health segments. Additionally, the company is interested in pursuing prescription markets and is open to partnerships with ethical companies to develop clinical studies focused on these populations.

Find out more

Muscle Wasting Publications

Download Now

Copyright © 2021 SNP Therapeutics, LLC - All Rights Reserved.

  • Home
  • Leadership Team

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept